JP Morgan Chase’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
Other funds holding GMED
JT
SC
JP Morgan Chase's GMED Position: Q2 2026 in Review
JP Morgan Chase increased its Globus Medical (GMED) stake by 5.7% in Q2 2026, buying an estimated $12.6M and bringing the position to 2,743,850 shares worth $231M. The position accounts for 0.01% of the portfolio, ranked #705.
JP Morgan Chase first reported a position in GMED in Q3 2013 and has held it in 48 quarters since. The position peaked at $271M in Q4 2025. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- JP Morgan Chase held 2,743,850 shares of Globus Medical worth $231M as of Q2 2026.
- JP Morgan Chase bought 148,542 Globus Medical shares in Q2 2026, an estimated $12.6M.
- Globus Medical made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #705 holding.
- JP Morgan Chase first reported a position in Globus Medical in Q3 2013 and has held it in 48 quarters since.
- JP Morgan Chase's Globus Medical position peaked at $271M in Q4 2025.
- 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.